Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prexasertib and Olaparib in Advanced Solid Tumors
NCT03057145Phase 1Completed
- Start
- Mar 2017
- Primary completion
- Feb 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of prexasertib in solid tumor. Started Mar 2017; status: completed.
02
Drugs
prexasertib
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT03057145.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03057145.